Skip to main content
. Author manuscript; available in PMC: 2010 Jan 29.
Published in final edited form as: Cancer Chemother Pharmacol. 2008 Mar 5;63(1):65. doi: 10.1007/s00280-008-0712-z

Table 6.

Docetaxel PK in patients treated with 30 mg/m2 in the presence of PI-88 compared with PK in patients treated with docetaxel alone

PK parameters Docetaxel + PI-88
(n = 11)
Docetaxel alonea
(n = 8)
Cmax (nM) 931 ± 347 933 ± 372
AUC (nM h) 1,390 ± 396 1,446 ± 494
t1/2α (h) 0.11 ± 0.04 0.08 ± 0.03
t1/2β (h) 1.24 ± 0.53 0.88 ± 0.49
t1/2γ (h) 33.0 ± 18.4 25.4 ± 20.1
CL (L/h/m2) 29.3 ± 10.7 29.1 ± 11.9
Vss (L/m2) 434 ± 358 322 ± 330

PK parameters calculated using a three-compartment model

a

Docetaxel alone data are from Gustafson et al. [20]